A spin-off enterprise from Harvard developing therapies that block signaling proteins causing disease is raising $51.5 million its first venture funding round. . . . → Read More: Protein Biotech Lands $51.5M in First Venture Round
|
|||||
       |
 One comment - (Comments are closed)  Finance  biomedical, biotechnology, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, software, university, venture capital Targeting tumors with chemotherapy delivered in nanoparticles, preceded with radiation, was shown in lab mice to boost treatments in a range of cancers. . . . → Read More: Radiation Enhances Nanoparticle Cancer Treatments One comment - (Comments are closed) New products biomedical, cancer, chemistry, life sciences, materials science, nanotechnology, patent, pharmaceuticals, physical sciences, preclinical Scanning electron micrograph of a human T-cell lymphocyte (National Institute of Allergy and Infectious Diseases, NIH) 29 June 2016. Biotechnology company Moderna Therapeutics and drug maker Merck are developing therapeutic vaccines using messenger RNA that address unique genetic patterns in patients’ tumors. The deal is expected to bring Moderna an immediate payment of . . . → Read More: Moderna, Merck Partner on Personal Cancer Vaccines One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, cancer, genomics, licensing, life sciences, manufacturing, pharmaceuticals (PublicDomainPictures, Pixabay) 29 June 2016. An analysis of regulatory approvals and outcomes shows medical devices are reviewed and approved faster in Europe than the U.S., but also face more safety issues later on. A team from Kings College London and Harvard University published its findings yesterday in the journal BMJ. Researchers led by . . . → Read More: More Device Approvals, Higher Risks in Europe than U.S. 2 comments - (Comments are closed) Regulations biomedical, clinical trials, economics, Europe, FDA, health care, medical device, U.K., university A company making leather for consumer goods with tissue engineering and gene-editing from living cells is raising $40 million in its second venture round. . . . → Read More: Animal-Free Leather Company Gains $40M in Venture Funds One comment - (Comments are closed) Finance agriculture, biotechnology, engineering, entrepreneurs, equity, genomics, investment, life sciences, materials science, physical sciences, venture capital Biomedical engineers developed a process for directly printing replacement cartilage without the scaffolds needed in previous tissue engineering techniques. . . . → Read More: 3-D Printing Technique Devised for Replacement Cartilage Comments are closed New products biomedical, engineering, life sciences, materials science, medical device, physical sciences, preclinical, university An academic-business initiative is providing pregnant women with more information on birth options, particularly Cesarean section surgery. . . . → Read More: Partnership Advising Women on C-Section Options One comment - (Comments are closed) Joint ventures/collaborations behavioral science, biomedical, health care, life sciences, medical device, software, university (skeeze, Pixabay) 27 June 2016. Department of Defense is funding research on new drugs that aim to improve the quality of tissue and limbs for transplants donated from people whose brains stop working. DoD awarded the grant of nearly $1 million to the Institute for Transformative Molecular Medicine at Case Western Reserve University . . . → Read More: Grant for Research on Drugs to Improve Tissue Transplants One comment - (Comments are closed) Finance, New products biomedical, DoD, grant, life sciences, pharmaceuticals, preclinical, university Crispr Therapeutics, a company creating treatments for disease that edit the human genome, is raising another $38 million in its second venture financing round. . . . → Read More: Genome Editing Company Adds $38M in Venture Funds Comments are closed Finance biomedical, biotechnology, entrepreneurs, equity, genomics, investment, life sciences, pharmaceuticals, venture capital A spin-off enterprise from Medical University of South Carolina is creating drug delivery techniques that make it safer for patients needing organ transplants. . . . → Read More: Start-Up Developing Nanomedicines for Transplants 3 comments - (Comments are closed) New products biomedical, chemistry, engineering, entrepreneurs, life sciences, medical device, nanotechnology, pharmaceuticals, physical sciences, preclinical, university |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts
You must be logged in to post a comment.